Company news from the 02/06/07 news brief
Schering-Plough has agreed to pay Anacor Pharmaceuticals of Palo Alto, CA up to $625 million for its toe-fungus treatment, dubbed ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.